C
ABVX

Covestor’s Abivax ABVX Stock Holding History

Covestor’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99K Sell
891
-83
-9% -$9.82K 0.07% 293
2025
Q4 		$131K Sell
974
-162
-14% -$17.7K 0.07% 409
2025
Q3 		$96K Buy
+1,136
New +$69.6K 0.05% 592
2025
Q2 		– Sell
-2,660
Closed -$17K – 2137
2025
Q1 		$17K Buy
+2,660
New +$18K 0.01% 1241

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Covestor's ABVX Position: Q1 2026 in Review

Covestor reduced its Abivax (ABVX) stake by 8.5% in Q1 2026, selling an estimated $9.82K and leaving 891 shares worth $99K. The position accounts for 0.07% of the portfolio, ranked #293.

Covestor first reported a position in ABVX in Q1 2025 and has held it in 4 quarters since. The position peaked at $131K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Covestor held 891 shares of Abivax worth $99K as of Q1 2026.
  • Covestor sold 83 Abivax shares in Q1 2026, an estimated $9.82K.
  • Abivax made up 0.07% of Covestor's portfolio in Q1 2026, its #293 holding.
  • Covestor first reported a position in Abivax in Q1 2025 and has held it in 4 quarters since.
  • Covestor's Abivax position peaked at $131K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.